Page 4 - Randomized Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The first day of the 109th Scientific Sessions and Annual Meeting of the Radiological Society of North America, RSNA 2023, delivered an engaging and highly-anticipated range of education and scientific sessions, technical exhibit floor demonstrations and news developments. Highlights from day one are summarized in this snapshot summary of several key programs and professional insights.

/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that five new presentations related to Peyronie's disease, or PD, and XIAFLEX® (collagenase...

Reported positive preliminary Phase 2 data on additional patients for HB-200 in combination with pembrolizumab in the 1st-line setting for advanced HPV16+ head and neck cancer; data reinforce strong objective response rate and disease control rate reported in Q2 2023; randomized trial expected to start in 2024 Published peer-reviewed preclinical data, in collaboration with Gilead Sciences, for HB-400 program in The Journal of Infectious Disease Recruitment ongoing for two Phase 1 clinical trials

Late-breaking trials will be presented during the main sessions and highlighted during press conferences scheduled for Oct. 24, 25 and 26

A liquid diet replaces solid food with liquids, such as meal shakes & smoothies. But does a liquid diet for weight loss really work in 2023?